
The Food and Drug Administration has warned pharma companies not to use two phthalates as excipients in both biological products and drugs, …

GlaxoSmithKline has announced the long-awaited decision on the location of its biopharmaceutical plant in the UK, with Ulverston in Cumbria …
Sweden’s Recipharm has been contracted by ViroPharma to carry out commercial-scale production of Plenadren (hydrocortisone modified release tablet), developed …
Sanofi has decided to close down a manufacturing facility in the North East of the UK with the loss of …

GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D. The multi-disciplinary scheme is …
The World Health Organization will join a shared inspection programme for active pharmaceutical ingredient (API) facilities piloted last year by …
Contract manufacturing and development organisation Patheon said it posted an operating loss in its fiscal first quarter results after losing …
The US FDA has sent a warning letter to surgical equipment manufacturer Synthes upbraiding it for deficiencies at a manufacturing …

Boehringer Ingelheim has said it plans to invest around €17 million in its biopharmaceutical development and manufacturing capabilities at Biberach, …
China’s Asymchem Laboratories says it plans to invest another $12 million in its recently-opened manufacturing facility in Dunhua, Jilin province, …
A consortium of industry associations has launched a certification scheme for pharmaceutical excipients to make it easier for drugmakers to …

Indian pharma company Ranbaxy will be banned from manufacturing drugs at certain plants for the US market until it corrects …
Abbott Laboratories has said it will cut 700 jobs across its US and Puerto Rican operations, including hundreds of manufacturing …
Contract development and manufacturing organisation Patheon has stepped up its position in the market for pharmaceutical capsules with the signing …
Efforts by Lundbeck to boost the productivity of its manufacturing operations have borne fruit, with the company cutting costs by …